[Relationship between rate of inactivation of isoniazid and changes in transaminase levels during combined isoniazid-rifampicin therapy (author's transl)].
D000107:Acetylation; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000037:antagonists & inhibitors* / Q000627:therapeutic use; D012293:Rifampin / Q000627:therapeutic use*; D013997:Time Factors; D000637:Transaminases / Q000097:blood*; D014397:Tuberculosis, Pulmonary / Q000188:drug therapy
D000637:Transaminases; D007538:Isoniazid; D012293:Rifampin
Die Bedeutung der INH-Schnell- und Langsaminaktivierer für die Transaminasenanstiege bei der kombinierten INH-RMP-Therapie